mebendazole
Also known as (5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester, MBDZ
Mebendazole (MBZ), sold under the brand name Vermox among others, is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm infection, hookworm infections, guinea worm infections and hydatid disease, among others. It has been used for treatment of giardiasis but is not a preferred agent. It is taken by mouth.
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 457797273
- Drug.image
- Mebendazole.svg
- Drug.image_class
- skin-invert-image
- Drug.image_class2
- bg-transparent
- Drug.width
- 225
- Drug.image2
- Mebendazole ball-and-stick model from xtal 2020.png
- Drug.tradename
- Vermox, Ovex, others
- Drug.MedlinePlus
- a682315
- Drug.DailyMedID
- Mebendazole
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
~5 min read
Article
9 sectionsContents
- Medical use
- Special populations
- Adverse effects
- Drug interactions
- Mechanism
- Society and culture
- Availability
- Economics
- References
Mebendazole (MBZ), sold under the brand name Vermox among others, is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm infection, hookworm infections, guinea worm infections and hydatid disease, among others. It has been used for treatment of giardiasis but is not a preferred agent. It is taken by mouth.
Mebendazole is usually well tolerated. Common side effects include headache, vomiting, and ringing in the ears. If used at large doses it may cause bone marrow suppression. It is unclear if it is safe in pregnancy. Mebendazole is a broad-spectrum antihelminthic agent of the benzimidazole type.